Updated ACVIM guidance prioritizes therapeutic diets and microbiome-directed therapy, identifying Visbiome Vet as the only probiotic currently backed by randomized clinical trial data for CIE.
February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results